| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.24 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |